Scalp cooling systems are used to treat hair loss caused by certain chemotherapeutic agents. Scalp Cooling/Cold cap can employ with all types of solid tumors that are treated with chemotherapeutic agents like alkylating agents (e.g. Cyclophosphamides), DNA intercalating agents/anthracyclines agents (e.g. doxorubicin) and taxanes (e.g. docetaxel). In cancer treatment, these drugs target rapidly dividing cell and keratinocytes matrix, which results in loss of hair. Scalp cooling systems work by reducing temperatures by a few degrees of the scalp. It can be used before, during or after the administration of chemotherapy.
Hair loss caused by certain chemotherapy drugs is treated with scalp cooling systems. Scalp Cooling/Cold Cap can be used to treat all forms of solid tumours that are being treated with chemotherapeutic agents such as alkylating agents (e.g., cyclophosphamides), DNA intercalating agents/anthracyclines agents (e.g., doxorubicin), and taxanes (e.g. docetaxel). In cancer treatment, these medications target fast dividing cells and the keratinocyte matrix, resulting in hair loss. Scalp cooling devices operate by lowering scalp temperatures by a few degrees. It can be used before to, during, or after chemotherapy treatment.
Global Scalp Cooling Systems market witnessed rapid growth due to rising demand for potential health benefits. Manufacturers are more focused toward developing advanced cooling systems to increase the acceptance. Due to less competition in the scalp cooling systems market, the companies are focused towards to development of new technology in scalp cooling. Companies work in partnership with research centers, charities, cancer support group, medical professionals, and patients to improve scalp cooling system technology and knowledge base. The future of Scalp Cooling Systems market is anticipated to grow at double CAGR during the forecast period.
No comments:
Post a Comment